Phibro Animal Health | PAHC - Cost Of Sales


Phibro Animal Health reported $240.42M in Cost of Sales for its fiscal quarter ending in December of 2025.





Cost Of Sales Change Date
Align Technology USD 363.97M 7.48M Dec/2025
ANI Pharmaceuticals USD 122.88M 6.86M Dec/2025
Assertio Holdings USD 8.89M 2.29M Jun/2024
Aurora Cannabis CAD 88.61M 30.53M Dec/2025
Bristol-Myers Squibb USD 4.92B 657M Dec/2025
Canopy Growth CAD 53.08M 8.3M Dec/2025
Corcept Therapeutics USD 2.54M 2.05M Dec/2025
Eli Lilly USD 3.37B 363.7M Dec/2025
Henry Schein USD 2.44B 62M Dec/2025
Idexx Laboratories USD 432.46M 10.58M Dec/2025
Knight Therapeutics CAD 82.22M 1.03M Dec/2025
Merck USD 3.32B 531M Dec/2025
Nektar Therapeutics USD 4.43M 5.3M Sep/2024
Pacira USD 54.62M 6.02M Dec/2025
Phibro Animal Health USD 240.42M 2.58M Dec/2025
Prestige Brands USD 131.22M 3.52M Dec/2025
Supernus Pharmaceuticals USD 47.53M 4.24M Dec/2025
Zoetis USD 743M 60M Dec/2025